FdaApplication

NDA 205208

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA
application_typeNDA
approval_date2013-10-11

Products (2)

ProductActive ingredientStrengthDosage form
DESVENLAFAXINEDESVENLAFAXINE FUMARATEEQ 50MG BASETABLET, EXTENDED RELEASE;ORAL
DESVENLAFAXINEDESVENLAFAXINE FUMARATEEQ 100MG BASETABLET, EXTENDED RELEASE;ORAL

2 products